Sabine Mai
Founder bij TELO GENOMICS CORP.
Vermogen: 295 095 $ op 29-02-2024
Profiel
Founder of Telo Genomics Corp., Sabine Mai is on the board of Telo Genomics Corp.
and The Genomic Centre For Cancer Research & Diagnosis and Professor at the University of Manitoba.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
TELO GENOMICS CORP.
3.95% | 08-12-2023 | 2 810 433 ( 3.95% ) | 295 095 $ | 29-02-2024 |
Actieve functies van Sabine Mai
Bedrijven | Functie | Begin |
---|---|---|
TELO GENOMICS CORP. | Founder | 25-05-2011 |
University of Manitoba | Corporate Officer/Principal | - |
The Genomic Centre For Cancer Research & Diagnosis | Director/Board Member | - |
Eerdere bekende functies van Sabine Mai
Bedrijven | Functie | Einde |
---|---|---|
3D Signatures, Inc. /Old/
3D Signatures, Inc. /Old/ Medical/Nursing ServicesHealth Services 3D Signatures, Inc. develops diagnostic and prognostic products. It provides diagnostic and prognostic tools for cancer and Alzheimer's disease. 3D Signatures is in the process of developing 3D Telo-PC for prostate cancer and 3D Telo-RS for Hodgkin’s Lymphoma. The company is headquartered in Winnipeg, Canada. | Director/Board Member | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
TELO GENOMICS CORP. | Health Services |
Bedrijven in privébezit | 2 |
---|---|
3D Signatures, Inc. /Old/
3D Signatures, Inc. /Old/ Medical/Nursing ServicesHealth Services 3D Signatures, Inc. develops diagnostic and prognostic products. It provides diagnostic and prognostic tools for cancer and Alzheimer's disease. 3D Signatures is in the process of developing 3D Telo-PC for prostate cancer and 3D Telo-RS for Hodgkin’s Lymphoma. The company is headquartered in Winnipeg, Canada. | Health Services |
The Genomic Centre For Cancer Research & Diagnosis |